Effect of high versus low doses of human recombinant erythropoietin on the anemia of prematurity

Acta Medica Iranica

Volumn 43, Issue 2, 2005, Pages 95-98

  Mohammadzadeh, A ^a   Naseri, F ^b  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anemia; Erythropoietin; Neonate; Prematurity

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ANEMIA; ARTICLE; BLOOD TRANSFUSION; CLINICAL ARTICLE; DIET SUPPLEMENTATION; DRUG EFFECT; DRUG MEGADOSE; ERYTHROPOIESIS; FEMALE; GESTATIONAL AGE; HEMATOCRIT; HUMAN; INFANT; IRON THERAPY; LOW DRUG DOSE; MALE; PREMATURITY; RETICULOCYTE COUNT;

EID: 26244451776     PISSN: 00446025     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Carbonell-Estrany X, Figueras-Aloy J. Anaemia of prematurity: treatment with erythropoietin. Early Hum Dev. 2001 Nov; 65 Suppl:S63-7.
2. Ferlin ML, Jorge SM, Ricco RG, Martinez FE. Prematurity anemia: effect of iron supplementation. Nutrition Research. 2001; 21 (1-2): 149-158.
3. Obladen M, Maier RF. Erythropoietin therapy in preterm infants: current Topics in Neonatology, New York; W.B.Saunders; 1997. p. 108-121.
4. Juul SE. Nonerythropoietic roles of erythropoietin in the fetus and neonate. Clin Perinatol. 2000 Sep; 27(3):527-541.
5. Halperin DS, Wacker P, Lacourt G, Felix M, Babel JF, Aapro M, Wyss M. Effects of recombinant human erythropoietin in infants with the anemia of prematurity: a pilot study. J Pediatr. 1990 May; 116(5):779-786.
6. Soubasi V, Kremenopoulos G, Diamanti E, Tsantali C, Sarafidis K, Tsakiris D. Follow-up of very low birth weight infants after erythropoietin treatment to prevent anemia of prematurity. J Pediatr. 1995 Aug; 127(2):291-297.
7. Shannon KM, Keith JF 3rd, Mentzer WC, Ehrenkranz RA, Brown MS, Widness JA, Gleason CA, Bifano EM, Millard DD, Davis CB, et al. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants. Pediatrics. 1995 Jan; m95(1):1-8.
8. Beck D, Masserey E, Meyer M, Calame A. Weekly intravenous administration of recombinant human erythropoietin in infants with the anaemia of prematurity. Eur J Pediatr. 1991 Sep; 150(11):767-772.
9. Carnielli V, Montini G, Da Riol R, Dall'Amico R, Cantarutti F. Effect of high doses of human recombinant erythropoietin on the need for blood transfusions in preterm infants. J Pediatr. 1992 Jul; 121(1):98-102.
10. Meyer MP, Meyer JH, Commerford A, Hann FM, Sive AA, Moller G, Jacobs P, Malan AF. Recombinant human erythropoietin in the treatment of the anemia of prematurity: results of a double-blind, placebo-controlled study. Pediatrics. 1994 Jun; 93(6 Pt 1):918-923.
11. Maier RF, Obladen M, Scigalla P, Linderkamp O, Duc G, Hieronimi G, Halliday HL, Versmold HT, Moriette G, Jorch G, et al. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group. N Engl J Med. 1994 Apr 28; 330(17):1173-1178.
12. Avent M, Cory BJ, Galpin J, Ballot DE, Cooper PA, Sherman G, Davies VA. A comparison of high versus low dose recombinant human erythropoietin versus blood transfusion in the management of anaemia of prematurity in a developing country. J Trop Pediatr. 2002 Aug; 48(4):227-33.
13. Meyer MP, Sharma E, Carsons M. Recombinant erythropoietin and blood transfusion in selected preterm infants. Arch Dis Child Fetal Neonatal Ed. 2003 Jan; 88(1):F41-45.